Comment on

• COX-2 selective inhibitors--important lessons learned.

  Maxwell SR, Webb DJ. Maxwell SR, et al. Lancet. 2005 Feb 5-11;365(9458):449-51. doi: 10.1016/S0140-6736(05)17876-3. Lancet. 2005. PMID: 15705439 No abstract available.
• Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

  Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA. Graham DJ, et al. Lancet. 2005 Feb 5-11;365(9458):475-81. doi: 10.1016/S0140-6736(05)17864-7. Lancet. 2005. PMID: 15705456